BoydNF, GuoH, MartinLJ, et al.Mammographic density and the risk and detection of breast cancer. N Engl J Med, 2007; 356:227–236.
2.
SpragueBL, GangnonRE, BurtV, et al.Prevalence of mammographically dense breasts in the United States. J Natl Cancer Inst, 2014; 106.
3.
HoussamiN, HunterK. The epidemiology, radiology and biological characteristics of interval breast cancers in population mammography screening. NPJ Breast Cancer, 2017; 3:12.
4.
CarneyPA, MigliorettiDL, YankaskasBC, et al.Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med, 2003; 138:168–175.
5.
CappelloNM.Decade of ‘normal’ mammography reports—The happygram. J Am Coll Radiol, 2013; 10:903–908.
6.
DenseBreast-info:. 2019. Available at: https://densebreast-info.org/legislation.aspx Accessed July25, 2021.
7.
NickelB, CoppT, BrennanM, FarberR, McCafferyK, HoussamiN. The impact of breast density information or notification on women's cognitive, psychological, and behavioral outcomes: A systematic review. J Natl Cancer Inst 2021 [Online ahead of print], DOI: 10.1093/jnci/djab016.
8.
NickelB, CoppT, BrennanM, FarberR, McCafferyK, HoussamiN. Breast density notification: A systematic review of the impact on primary care practitioners. J Womens Health (Larchmt), 2021; 30:1457–1468.
9.
ColditzGA, BohlkeK. Priorities for the primary prevention of breast cancer. CA Cancer J Clin, 2014; 64:186–194.
10.
KeatingNL, PaceLE. New federal requirements to inform patients about breast density: will they help patients?. JAMA, 2019; 321:2275–2276.
11.
BakkerMF, de LangeSV, PijnappelRM, et al.Supplemental MRI screening for women with extremely dense breast tissue. N Engl J Med, 2019; 381:2091–2102.
12.
LongoDL.Detecting breast cancer in women with dense breasts. N Engl J Med, 2019; 381:2169–2170.
13.
MelnikowJ, FentonJJ, WhitlockEP, et al.Supplemental screening for breast cancer in women with dense breasts: A systematic review for the U.S. Preventive Services Task Force. Ann Intern Med, 2016; 164:268–278.
14.
HuangS, HoussamiN, BrennanM, NickelB. The impact of mandatory mammographic breast density notification on supplemental screening practice in the United States: A systematic review. Breast Cancer Res Treat, 2021; 187:11–30.
15.
JohanssonM, BrodersenJ. Informed choice in screening needs more than information. Lancet, 2015; 385:1597–1599.
16.
HaasJS, GiessCS, HarrisKA, AnsolabehereJ, KaplanCP. Randomized trial of personalized breast density and breast cancer risk notification. J General Intern Med, 2019; 34:591–597.
17.
ManningM, PurringtonK, PennerL, DuricN, AlbrechtTL. Between-race differences in the effects of breast density information and information about new imaging technology on breast-health decision-making. Patient Educ Counsel, 2016; 99:1002–1010.
18.
NguyenDL, AmbinderEB, JonesMK, MullenLA, HarveySC. Improving state-mandated breast density notifications. J Am Coll Radiol, 2020; 17:384–390.
19.
BowlesE, O'NeillS, LiT, et al. Effect of a randomized trial of a web-based intervention on patient-provider communication about breast density. J Womens Health 2021 [Epub ahead of print].
20.
WernliKJBE, KnerrS, et al.Characteristics associated with participation in ENGAGED 2—A web-based breast cancer risk communication and decision support trial. Perm J, 2020; 24:205.